| RS140180561 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1401805753 |
F8
|
Health Risk |
Pathogenic |
Hereditary factor VIII deficiency disease, Hereditary factor VIII deficiency disease |
| RS1401810953 |
ENPP1
|
Health Risk |
Pathogenic |
Arterial calcification, generalized |
| RS1401811144 |
CPT1A
|
Health Risk |
Likely pathogenic |
Carnitine palmitoyl transferase 1A deficiency, Carnitine palmitoyl transferase 1A deficiency |
| RS140181682 |
AMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Muscle AMP deaminase deficiency, AMPD1-related disorder |
| RS1401818080 |
HGSNAT
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 73 |
| RS140182370 |
LRP6
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant polycystic liver disease, Inborn genetic diseases |
| RS1401825950 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1401829291 |
DBT
|
Health Risk |
Pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS140183285 |
ANK3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability-hypotonia-spasticity-sleep disorder syndrome, Inborn genetic diseases |
| RS1401834885 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1401839892 |
CTNNA1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, CTNNA1-associated FEVR |
| RS140184279 |
VARS2
|
Health Risk |
Conflicting classifications of pathogenicity |
Combined oxidative phosphorylation defect type 20, Combined oxidative phosphorylation defect type 20 |
| RS140184929 |
UNC13D
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial hemophagocytic lymphohistiocytosis 3, Autoinflammatory syndrome |
| RS140186161 |
LRP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cenani-Lenz syndactyly syndrome, Sclerosteosis 2 |
| RS1401866270 |
ARID1B
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1401870617 |
OTOG
|
Health Risk |
Likely pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS140187237 |
EP300
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, EP300-related disorder |
| RS1401878479 |
FGD4
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 4, Charcot-Marie-Tooth disease type 4 |
| RS140188204 |
BICD2
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant childhood-onset proximal spinal muscular atrophy with contractures, Inborn genetic diseases |
| RS1401882647 |
ACAT1
|
Health Risk |
Likely pathogenic |
Deficiency of acetyl-CoA acetyltransferase, Deficiency of acetyl-CoA acetyltransferase |
| RS140188898 |
CD2AP
|
Health Risk |
Conflicting classifications of pathogenicity |
Focal segmental glomerulosclerosis 3, susceptibility to |
| RS140188939 |
TYROBP
|
Health Risk |
Conflicting classifications of pathogenicity |
TYROBP-related disorder, TYROBP-related disorder |
| RS1401892400 |
ABCB11
|
Health Risk |
Pathogenic/Likely pathogenic |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS140189724 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiovascular phenotype, Long QT syndrome |
| RS140190002 |
CLDN19
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Renal hypomagnesemia 5 with ocular involvement |
| RS1401903524 |
MAPT
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140190776 |
F11
|
Health Risk |
Likely pathogenic |
Plasma factor XI deficiency, F11-related disorder |
| RS140191063 |
TCIRG1
|
Health Risk |
Conflicting classifications of pathogenicity |
TCIRG1-related disorder, TCIRG1-related disorder |
| RS140191153 |
PSMD12
|
Health Risk |
Likely pathogenic |
Stankiewicz-Isidor syndrome, Stankiewicz-Isidor syndrome |
| RS140191309 |
PLEC
|
Health Risk |
Conflicting classifications of pathogenicity |
Epidermolysis bullosa simplex with nail dystrophy, Autosomal recessive limb-girdle muscular dystrophy type 2Q |
| RS140191346 |
TMEM67
|
Health Risk |
Conflicting classifications of pathogenicity |
Joubert syndrome 1, Joubert syndrome |
| RS140192152 |
CNNM4
|
Health Risk |
Conflicting classifications of pathogenicity |
Jalili syndrome, Inborn genetic diseases |
| RS140192228 |
RPL3L
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140192398 |
SPATA7
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Leber congenital amaurosis 3 |
| RS1401924846 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1401928680 |
G6PC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to glucose-6-phosphatase deficiency type IA, Glycogen storage disease due to glucose-6-phosphatase deficiency type IA |
| RS140193292 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Dilated cardiomyopathy 1BB |
| RS140194114 |
COL1A2
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS140194348 |
C2
|
Health Risk |
Conflicting classifications of pathogenicity |
Age related macular degeneration 14, Complement component 2 deficiency |
| RS1401949733 |
GLDC
|
Health Risk |
Likely pathogenic |
Glycine encephalopathy, Glycine encephalopathy |
| RS1401956029 |
ABCB4
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 3, Inborn genetic diseases |
| RS140195786 |
LRP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Donnai-Barrow syndrome, LRP2-related disorder |
| RS140196414 |
AIRE
|
Health Risk |
Conflicting classifications of pathogenicity |
Polyglandular autoimmune syndrome, type 1 |
| RS140196536 |
RHBDF2
|
Health Risk |
Conflicting classifications of pathogenicity |
Palmoplantar keratoderma-esophageal carcinoma syndrome, Inborn genetic diseases |
| RS140196582 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant nonsyndromic hearing loss 6, WFS1-Related Spectrum Disorders |
| RS140198185 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1401986830 |
MAGEL2
|
Health Risk |
Likely pathogenic |
— |
| RS1401990024 |
CCP110
|
Health Risk |
Likely pathogenic |
See cases, See cases |
| RS140199177 |
TREX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Aicardi-Goutieres syndrome 1, Chilblain lupus 1 |
| RS140199241 |
AHDC1
|
Health Risk |
Conflicting classifications of pathogenicity |
AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome, AHDC1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome |
| RS1401992478 |
DYSF
|
Health Risk |
Likely pathogenic |
Neuromuscular disease caused by qualitative or quantitative defects of dysferlin, Miyoshi muscular dystrophy 1 |
| RS140200789 |
SLC26A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Atelosteogenesis type II, Diastrophic dysplasia |
| RS140201404 |
GYS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease due to muscle and heart glycogen synthase deficiency, Glycogen storage disease due to muscle and heart glycogen synthase deficiency |
| RS140201636 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS140202046 |
LAMA2
|
Health Risk |
Conflicting classifications of pathogenicity |
LAMA2-related muscular dystrophy, Merosin deficient congenital muscular dystrophy |
| RS140202230 |
IFT80
|
Health Risk |
Conflicting classifications of pathogenicity |
Jeune thoracic dystrophy, Type IV short rib polydactyly syndrome |
| RS140202346 |
TUBA8
|
Health Risk |
Conflicting classifications of pathogenicity |
Polymicrogyria with optic nerve hypoplasia, Polymicrogyria with optic nerve hypoplasia |
| RS140202512 |
SMPD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Niemann-Pick disease, type B |
| RS140202552 |
CUBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Imerslund-Grasbeck syndrome, Proteinuria |
| RS140202670 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS140202819 |
CLSTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140202956 |
USH2A
|
Health Risk |
Likely pathogenic |
Usher syndrome type 2A, USH2A-related disorder |
| RS1402031100 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1402033817 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS140204495 |
DAG1
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal recessive limb-girdle muscular dystrophy type 2P, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS140205115 |
CLCN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Batten-Turner congenital myopathy, Congenital myotonia |
| RS140205536 |
KCNH5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1402071263 |
RELN
|
Health Risk |
Conflicting classifications of pathogenicity |
Norman-Roberts syndrome, Familial temporal lobe epilepsy 7 |
| RS140207251 |
PROP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Pituitary hormone deficiency, combined |
| RS140207606 |
ABCG2
|
Health Risk |
association |
BLOOD GROUP, JUNIOR SYSTEM |
| RS140208002 |
BSCL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Congenital generalized lipodystrophy type 2, Neuronopathy |
| RS140208061 |
AHNAK2
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140208362 |
DNM2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease dominant intermediate B, Autosomal dominant centronuclear myopathy |
| RS1402086660 |
RUSC2
|
Health Risk |
Pathogenic |
Intellectual disability, autosomal recessive 61 |
| RS140208683 |
ENTREP1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1402090677 |
ABCC8
|
Health Risk |
Conflicting classifications of pathogenicity |
Hyperinsulinemic hypoglycemia, familial |
| RS140209136 |
CFAP418
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinitis pigmentosa, Cone-rod dystrophy 16 |
| RS1402092076 |
IKBKB
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe combined immunodeficiency due to IKK2 deficiency, Severe combined immunodeficiency due to IKK2 deficiency |
| RS1402092579 |
TBK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Frontotemporal dementia and/or amyotrophic lateral sclerosis 4, Amyotrophic lateral sclerosis |
| RS140209484 |
SH3PXD2B
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1402095850 |
TRAPPC9
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS140210148 |
SLC26A8
|
Health Risk |
Pathogenic |
Spermatogenic failure 3, Spermatogenic failure 3 |
| RS140211194 |
PIGL
|
Health Risk |
Conflicting classifications of pathogenicity |
CHIME syndrome, CHIME syndrome |
| RS1402132413 |
CYP17A1
|
Health Risk |
Pathogenic |
Deficiency of steroid 17-alpha-monooxygenase, Deficiency of steroid 17-alpha-monooxygenase |
| RS1402133337 |
CR2
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS140213840 |
MMP20
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta hypomaturation type 2A2, MMP20-related disorder |
| RS1402138776 |
ACTN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Primary familial hypertrophic cardiomyopathy, Dilated cardiomyopathy 1AA |
| RS1402140155 |
HADH
|
Health Risk |
Pathogenic/Likely pathogenic |
Deficiency of 3-hydroxyacyl-CoA dehydrogenase, Deficiency of 3-hydroxyacyl-CoA dehydrogenase |
| RS140214637 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group U |
| RS1402147578 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS140215004 |
CACNA1D
|
Health Risk |
Conflicting classifications of pathogenicity |
Sinoatrial node dysfunction and deafness, Aldosterone-producing adenoma with seizures and neurological abnormalities |
| RS1402161985 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1402162002 |
XPC
|
Health Risk |
Pathogenic |
Xeroderma pigmentosum, group C |
| RS1402167763 |
TYR
|
Health Risk |
Likely pathogenic |
TYR-related disorder, TYR-related disorder |
| RS1402168594 |
PAH
|
Health Risk |
Likely pathogenic |
Phenylketonuria, Phenylketonuria |
| RS140217223 |
FTCD
|
Health Risk |
Pathogenic |
Glutamate formiminotransferase deficiency, Inborn genetic diseases |
| RS1402175424 |
ZSWIM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1402176902 |
NOTCH3
|
Health Risk |
Pathogenic |
— |
| RS1402177037 |
MME
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |